I read this article and the related document several times. I might have gotten this wrong, but here's an excerpt from the article:
To summarize the findings of a study conducted by NHS England:
1 - There was a 2,000% increase in trans-related referrals in the last decade.
2 - There is a marked, poorly understood change in the types of patients being referred.
3 - Thee is scarce and inconclusive international evidence to support clinical decision making.
NHS commissioning » Implementing advice from the Cass Review
We are now going out to targeted stakeholder testing on an interim clinical commissioning policy proposing that, outside of a research setting, puberty suppressing hormones should not be routinely commissioned for children and adolescents who have gender incongruence/dysphoria.
To summarize the findings of a study conducted by NHS England:
1 - There was a 2,000% increase in trans-related referrals in the last decade.
2 - There is a marked, poorly understood change in the types of patients being referred.
3 - Thee is scarce and inconclusive international evidence to support clinical decision making.
NHS commissioning » Implementing advice from the Cass Review